Navigation Links
Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
Date:5/31/2008

picoplatin is being evaluated in a Phase 1 clinical trial in solid tumors. The oral formulation of picoplatin has the same active pharmaceutical ingredient as the intravenous formulation. Picoplatin has not been approved by any regulatory authority for use in humans.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. For additional information please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's business objectives and strategic goals, drug development plans, results of clinical trials and the potential safety and efficacy of its products in development. The Company's actual results may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of pre-clinical and clinical testing; the receipt and timing of required regulatory approvals; the market's acceptance of the Company's proposed products; the Company's anticipated operating losses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2007 and Quarterl
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting
2. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
3. Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
4. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
5. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
6. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
7. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
10. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
11. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 LifeScienceIndustryResearch.com adds ... Syringe Industry of 178 pages providing 10 ... library. The 2014 Market Research ... a professional and deep research report on ... the report introduces Disposable Syringe basic information ...
(Date:12/24/2014)... , Dec. 23, 2014 Tianyin ... company that specializes in patented biopharmaceutical, modernized traditional ... ingredients (API) today announced that the Company achieved ... Good Manufacturing Practice (GMP) certificate of TPI,s Qionglai ... Administration,s (CFDA). The public notice period is a ...
(Date:12/22/2014)... Dec. 22, 2014 NxStage Medical, Inc. (NASDAQ: ... innovative dialysis products, announced today that the U.S. ... System One™ to perform hemodialysis overnight while the ... nocturnal hemodialysis. NxStage,s® System One is the first ... for this indication. Home nocturnal ...
Breaking Medicine Technology:World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3
... 23, 2011 TRX, Inc. ( www.trx.com ) ... process automation, consulting and data services, announced continued ... several leading companies in the pharmaceutical, technology, financial ... to manage their travel and procurement reporting needs. ...
... Relievant Medsystems, Inc. , today announced the ... and chief executive officer and as a member of ... FDA approval of an Investigational Device Exemption (IDE) to ... of RF Ablation for the Treatment of Vertebrogenic Back ...
Cached Medicine Technology:TRX's Data Intelligence Solution, TRAVELTRAX, Helps Fortune 500 Corporations Gain New Insights Into Cost Savings 2Relievant Medsystems Appoints Alex M. DiNello as President and Chief Executive Officer 2
(Date:12/26/2014)... 2014 Cooking and warming equipment ... of 5. This score reflects slightly positive negotiation conditions ... specialization, low switching costs and a low level of ... low availability of substitutes for cooking and warming equipment ... and aluminum, key inputs in the production process of ...
(Date:12/26/2014)... The Biofeedback Federation of Europe annual ... in Rome, Italy and is hosted by the Salesian ... on a wide variety of topics such as ADHD, ... training in athletes. The scientific program will feature the ... monitoring allows clients to see what is going on ...
(Date:12/26/2014)... 2014 “Many people become overwhelmed by ... claim issues and phone calls with insurance companies,” The ... featuring their free eBook on pedestrian and bicycle ... pedestrian and bicycle auto accident claims assures the injured ... of professionally handling their case while they focus on ...
(Date:12/26/2014)... December 26, 2014 Pentec Health, Inc. ... the state of Pennsylvania for 2014. The awards program, ... programs of its kind in the country. The program ... Pennsylvania Department of Community and Economic Development, the Pennsylvania ... and the Central Penn Business Journal. , ...
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3
... IRVING, Texas, Nov. 20 RBC Life Sciences, Inc. ... care and pain management products, reported today company-wide net sales of ... net sales of $9.93 million for the same quarter last year. ... $0.01 per share, during the third quarter of 2009, compared to ...
... 20 An emerging body of ... infectious disease transmission patterns. As noted today in a ... of Tropical Medicine and Hygiene (ASTMH), such changes are expected ... "There is concrete evidence that the global climate is changing, ...
... ... ... 20, 2009 -- Late yesterday, democratic leaders in the Senate unveiled their proposal for overhauling ... Democrats argue that the tax, which was a surprise addition to the sweeping 2,074-page bill, ...
... Grant provides hot food to 150 children under 5 for six months ... (TPRF) has given a grant of US $15,000 to provide food for ... victims of recent typhoons in the Rizal province in the Philippines. , ... (PNRC) for a sustainable hot meal program. The delivery of ...
... Honor Recognizes Courageous and Innovative Approaches to Human Rights ... at its annual awards dinner, the Robert F. Kennedy Center ... with the organization,s 2009 Ripple of Hope Award. The ... on humanitarian issues. , (Logo: http://www.newscom.com/cgi-bin/prnh/20091119/DC149610 ) ...
... High irradiances of low-level laser therapy (LLLT) should not be ... BMC Cancer studied the pain relieving, anti-inflammatory ,cold ... mouse model of skin cancer. Jan M. Bjordal from ... researchers to carry out the in vitro and in vivo ...
Cached Medicine News:Health News:RBC Life Sciences Announces Third Quarter 2009 Results 2Health News:RBC Life Sciences Announces Third Quarter 2009 Results 3Health News:RBC Life Sciences Announces Third Quarter 2009 Results 4Health News:RBC Life Sciences Announces Third Quarter 2009 Results 5Health News:Experts Examine Possible Links Between Climate Change and Infectious Disease Transmission 2Health News:Experts Examine Possible Links Between Climate Change and Infectious Disease Transmission 3Health News:Plastic Surgeons Respond To Proposed Cosmetic Surgery Tax 2Health News:Plastic Surgeons Respond To Proposed Cosmetic Surgery Tax 3Health News:The Prem Rawat Foundation Gives Food Aid to Typhoon Victims in Philippines 2Health News:Bono and Wyclef Jean Receive RFK Center for Justice & Human Rights' Ripple of Hope Award 2Health News:Bono and Wyclef Jean Receive RFK Center for Justice & Human Rights' Ripple of Hope Award 3
... Oxoid Pylori Test is a ... the qualitative detection of Helicobacter ... as an aid in the ... pylori. The product is intended ...
... capillary electrophoresis system is designed to ... The CAPILLARYS 2 utilizes liquid flow ... diagnostic setting. Through continuous sample feed ... narrow capillary tubes functioning concurrently, a ...
Inquire...
These Iron Control Slides make an excellent addition to your laboratory. Packed ten (10) control slides per box. Use SDL's Snap n' Stain for Iron Staining Kit alongside to save time an money mixing r...
Medicine Products: